J3-2128 — Final report
1.
Peripheral arterial disease in Slovenia - a national problem?

The lecture deals with the magnitude and significance of the problem, frequent dilemmas and questions, frequent mistakes, urgent management, what can general physician do, what can hospital specialist do and how to avoid mistakes and faults in managing peripheral arterial disease.

B.04 Guest lecture

COBISS.SI-ID: 622508
2.
Is it possible to prevent CV events in PAD patients? (Results of PID-PAB study)

Peripheral arterial disease (PAD) is associated with frequent cardiovascular ischemic events. We followed the survival of 811 PAD patients and and 778 control subjects and tested whether PAD remains an adverse prognostic indicator in spite of treatment according to the current European guidelines on cardiovascular disease prevention. Patients with PAD had a borderline higher risk of all-cause death and a significantly higher risk of major and minor non-fatal cardiovascular events compared to control subjects. However, treatment according to the European guidelines on cardiovascular disease prevention resulted in encouragingly low absolute mortality and morbidity.

B.03 Paper at an international scientific conference

COBISS.SI-ID: 29349081
3.
ESC guidelines on the diagnosis and treatment of peripheral artery diseases

Guidelines summarize and evaluate all available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategies for an individual patient, with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help the physicians to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible physician(s).

F.11 Development of a new service

COBISS.SI-ID: 29098969
4.
Peripheral arterial disease

Peripheral arterial disease is caused by advanced atherosclerosis, which narrows and finaly occludes diseased artery. In the developed world morbidity is high. Two % of population develops the disease before 60 years of age, 4% between 60 and 7o years and 5% after 70 years of age. If patients are diabetics or smoke, morbidity increases by 5-fold.

B.04 Guest lecture

COBISS.SI-ID: 29517273
5.
Prevention of ishemic events in patients with peripheral arterila disease-5 year results of a prospective, observational study

Peripheral arterial disease (PAD) carries a high risk of cardiovascular events and has a historically reported 5-years survival rate of only 70-80%. In the study 813 patients with PAD and 778 control subjects were included into 5-year prospective observational study. All subjects were treated according to the European guidelines on cardiovascular disease prevention. The 5 year survival estimate was 88.5% in patients with PAD and 95.0% in controls. It was concluded that treatment according to European guidelines resulted in encouragingly low absolute mortality and morbidity of PAD patients.

B.04 Guest lecture

COBISS.SI-ID: 288940